Header Logo

Connection

Steven Bines to Cytopathogenic Effect, Viral

Back to Details
This is a "connection" page, showing publications Steven Bines has written about Cytopathogenic Effect, Viral.
Steven Bines
Connection Strength
0.088
Cytopathogenic Effect, Viral
  1. OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma. Future Oncol. 2010 Jun; 6(6):941-9.
    View in: PubMed
    Score: 0.088
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.